Sponsor:
Hal Chapman
Code:
NCT06265532
Conditions
Idiopathic Pulmonary Fibrosis
Eligibility Criteria
Sex: All
Age: 40 - 70+
Healthy Volunteers: Not accepted
Interventions
EGCG 300 mg
Placebo for EGCG 300 mg
EGCG 600 mg
Placebo for EGCG 600 mg
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by Hal Chapman on 2024-11-18.